Literature DB >> 10332668

Is there a glycemic threshold for mortality risk?

B Balkau1, S Bertrais, P Ducimetiere, E Eschwege.   

Abstract

OBJECTIVE: To determine whether there are thresholds for fasting and for 2-h glucose above which the risk of death from all causes and from coronary heart disease (CHD) increases. RESEARCH DESIGN AND METHODS: We studied 23-year mortality data from the Paris Prospective Study of the 7,018 men, aged 44-55 years, who were not known as diabetic at the baseline examination. The effect of glucose concentrations on mortality was studied using the observed relative risks and an age-adjusted Cox proportional hazards model.
RESULTS: For all causes of death, there were J-shaped relationships with both fasting and 2-h glucose concentrations, and the lowest observed death rates were in the intervals centered on 5.5 mmol/l for fasting glucose and 5.0 mmol/l for 2-h glucose. The death rates for CHD were low in this population: for fasting glucose, the hazards ratio was best modeled by a positive linear relationship; for 2-h glucose, it was modeled by a J-shaped curve and the lowest observed death rate was in the interval centered on 6.0 mmol/l.
CONCLUSIONS: In the Paris Prospective Study, there were no clear thresholds for fasting or 2-h glucose concentrations above which mortality sharply increased; in the upper levels of the glucose distributions, the risk of death progressively increased with increasing fasting and 2-h glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332668     DOI: 10.2337/diacare.22.5.696

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 2.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

3.  Inverse association between fasting plasma glucose and risk of ventricular arrhythmias.

Authors:  Francesco Zaccardi; David R Webb; Sudhir Kurl; Kamlesh Khunti; Melanie J Davies; Jari A Laukkanen
Journal:  Diabetologia       Date:  2015-06-03       Impact factor: 10.122

Review 4.  Effects of macronutrient excess and composition on oxidative stress: relevance to diabetes and cardiovascular disease.

Authors:  Antonio Ceriello
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

Review 5.  Glucokinase MODY and implications for treatment goals of common forms of diabetes.

Authors:  Ramzi A Ajjan; Katharine R Owen
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

6.  Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Authors:  Rajendra Pradeepa; Adamsha Nazir; Viswanathan Mohan
Journal:  Heart Asia       Date:  2012-01-01

7.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

Authors:  B Balkau; G Hu; Q Qiao; J Tuomilehto; K Borch-Johnsen; K Pyörälä
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

8.  Blood glucose control and coronary heart disease.

Authors:  Cristina Bianchi; Giuseppe Penno; Roberto Miccoli; Stefano Del Prato
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

9.  Diabetes increases large artery diseases, but not small artery diseases in the brain.

Authors:  Beom Joon Kim; Seung-Hoon Lee; Bong Su Kang; Byung-Woo Yoon; Jae-Kyu Roh
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

10.  Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

Authors:  E L M Barr; E J Boyko; P Z Zimmet; R Wolfe; A M Tonkin; J E Shaw
Journal:  Diabetologia       Date:  2009-01-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.